Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling pathway
Background: Hypo-fractionation radiotherapy (HFRT) was considered to be an important treatment for non-small cell lung cancer (NSCLC), but the radiobiological effects of HFRT on NSCLC remain unclear. The aim of this study was to investigate specific biological effect of HFRT on tumor angiogenesis, c...
Main Authors: | Fan Tong, Chun-jin Xiong, Chun-hua Wei, Ye Wang, Zhi-wen Liang, Hui Lu, Hui-jiao Pan, Ji-hua Dong, Xue-feng Zheng, Gang Wu, Xiao-rong Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758835920965853 |
Similar Items
-
Retrospective Analysis of Efficacy and Toxicity of Hypo-fractionated Radiotherapy in Breast Carcinoma
by: Ritusha Mishra, et al.
Published: (2016-08-01) -
Model-Supported Radiotherapy Personalization: In silico Test of Hyper- and Hypo-Fractionation Effects
by: Antonella Belfatto, et al.
Published: (2018-10-01) -
Investigation of irradiated volume in linac-based brain hypo-fractionated stereotactic radiotherapy
by: Mark Ruschin, et al.
Published: (2017-07-01) -
Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM
by: Leor Zach, et al.
Published: (2021-08-01) -
A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer
by: Ning Li, et al.
Published: (2018-08-01)